The cost savings of consultant pharmacy practice and drug-related problems and care outcomes of dealing with the geriatric patients at all levels of care are reviewed. The consultant pharmacist has been shown to decrease overall drug costs, adverse drug reactions, and drug-related hospitalizations and mortality, while improving the quality of drug therapy and actually lowering drug monitoring costs. Problems and issues yet to be resolved are presented along with recommendations for improved quality of pharmacy services and education.
Get full access to this article
View all access options for this article.
References
1.
Eckel FM, Latiolais CJ: An analysis of pharmaceutical service in forty-one nursing homes. Am J Hosp Pharm21:351-360, 1964
2.
McLeod DC, Eckel FM: Relationship between method of reimbursement and scope of pharmacy service in nursing homes. J Am Pharm Assoc9:62-64, 1969
3.
Eckel FM, Crawley HK: A study of pharmacy services in North Carolina rest homes. J Am Pharm Assoc11:387-390, 1971
4.
Eckel FM: Improving system didn't help—but change to unit dose did. Mod Nurs Home71:10-16, 1971
5.
Crawley HK, Eckel FM, McLeod DC: Comparison of a traditional and unit-dose system in a nursing home . Drug Intell Clin Pharm5:166-171, 1971
6.
Townsend C.: Old Age—The Last Segregation. New York, Grossman, 1971
7.
Department of Health, Education, and Welfare: Nursing home care in the United States; Failure in public policy. Supporting papers series. US Congress Special Committee on Aging, United States Senate, Subcommittee on Long Term Care, 1974 -1978
8.
Department of Health, Education, and Welfare: Long term care facility improvement study. Introductory report. DHEW No. (05) 76-50021. 1975
9.
Department of Health, Education, and Welfare: Physician's prescribing patterns in skilled nursing facilities. LTCF improvement campaign Monograph No. 2 DHEW No. (05) 76-50050, 1976
10.
Department of Health, Education, and Welfare : Problems remain in reviews of medicaid-financed drug therapy in nursing homes. Report to the Congress by the Comptroller General . DHEW No. HRD-80-56, 1980
11.
Cheung A., Kayne R.: An application of clinical pharmacy in extended care facilities. Calif Pharm23:22-25, 1975
12.
Thompson J. , Floyd R.: Cost-analysis of comprehensive consultant pharmacist services in the skilled nursing facility: A progress report. Calif Pharm26:22-26, 1978
13.
Cooper JW, Bagwell CG: Contribution of the consultant pharmacist to rational drug usage in the long-term care facility. J Am Ger Soc26:513-520, 1978
14.
Strandberg LR, Dawson GW, Mathieson D. et al: Effect of comprehensive pharmaceutical services on drug use in long-term care facilities. Am J Hosp Pharm37:92-94, 1980
15.
Witte KW, Leeds NH, Pathak DS, et al: Drug-regimen review in skilled nursing facilities by consulting clinical pharmacists. Am J Hosp Pharm37:820-824, 1980 16. McGhan WF, Wertheimer AI, Martilla JK: Assessing the need for pharmacist-conducted drug regimen reviews in skilled nursing and intermediate care facilities. Contemp Pharm Prac3:203-209, 1980
16.
McGhan WF, Einarson TR, Sabers DL, et al: A meta-analysis of the impact of pharmacist drug regimen reviews in long-term care facilities. J GerDrug Ther1:23-35, 1987
17.
Barker KN, Mikeal RL, Pearso RE: Medication errors in nursing homes and small hospitals. Am J Hosp Pharm39:987-991, 1982
18.
Strandberg L., Stennett D.: Drug distribution systems in Oregon's long term care facilities. Hosp Form29:627-637, 1981
19.
Cooper JW: Effects of intensive consultant pharmacy review of nursing home admission orders. Consult Pharm2:152-155, 198?
20.
Cooper JW: Drug-related problems in a geriatric long term care facility. J GerDrug Ther1:47-68, 1986
21.
Cooper JW: Effect of initiation, termination and reinitiation of consultant clinical pharmacists services in a geriatric long term care facility. Med Care23:84-88, 1985
22.
Thompson JF, McGhan WF, Ruffalo RL, et al: Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Ger Soc32:154-159, 1984
23.
Williamson DH , Cooper JW, Kotzan JA: Consultant pharmacist impact on hypertension therapy in a geriatric long term care facility. Hosp Form19:123-128, 1984
24.
Pink LA, Cooper JW, Francis WR: Digoxin-related communications in a long term care facility. Nursing Homes34:25-31, 1985
25.
Wilcher DE, Cooper JW: Consultant pharmacist effect on analgesic/antiinflammatory usage in a geriatric long term care facility. J Am Ger Soc29:429-432, 1981
26.
Cooper JW, Mallet L., Wade WE: Anemia prevalence and treatment outcomes in a geriatric long term care facilities population. J Pharmacoepid (in press)
27.
Cooper JW and Cobb HH: Nutritional correlates and outcomes in a geriatric long term care facility . Nutr Supp Serv (in press)
28.
Tsai AE, Cooper JW, McCall CY: Consultant pharmacist effect on hematopoietic and vitamin therapy in a geriatric long term care facility. Hosp Form17:225-235, 1982
29.
Cooper JW, Francisco GE: Psychotropic usage in long term care facility geriatric patients. Hosp Form16:407-419, 1981
30.
Wade WE, Cobb HH: Consultant pharmacist effects on seizure control in an institution for mentally retarded. Consult Pharm2:156-158, 1987
31.
Cooper JW: Chronic constipation correlates and prevention in a geriatric nursing home population. Am J Gastroent (in press)
32.
Cooper JWConsultant pharmacist contribution to reduction of eye infections in a geriatric nursing home. Consult Pharm3:83, 1988
33.
Lawler RS, Cooper JW, Kotzan JA: Consultant pharmacist input to treatment of urinary tract infections in a geriatric long term care facility. Hosp Pharm15:562-572, 1980
34.
Cooper JW, Griffin DH, Francisco GE, et al: Pharmacist in home health care. Hosp Form20:643-650, 1985.
35.
Solomon DK: Baumgartner RP, Weissman AM, et al: Pharmaceutical services to improve drug therapy for home health care patients. Am J Hosp Pharm35:553-557, 1978
36.
Szeinbach SL , Bonk DS, Mason HL: Pharmacy involvement in home health care agencies: A national survey. Consult Pharm2:292-296, 1987
37.
Cooper JWDrug-related problems in geriatric day-care patients. Consult Pharm3:193, 1988
38.
Cooper JW: Swing bed patients and the consultant pharmacist. Consult Pharm3:287, 1988
39.
Cooper JW: Appropriate utilization of laboratory tests in the geriatric nursing home . Nursing Homes (in press)
40.
Cooper JW: Nursing home drug and nutritional therapy cost-savings by the consultant pharmacist . Nursing Homes36:6-8, 1987
41.
Cooper JW: Cost-savings from discontinuance of urinary sugar and acetone tests . Consult Pharm3:83, 1988
42.
Wade WE, Talley SE: Consultant Pharmacist effect on private vs. public patients in geriatric nursing homes. Consult Pharm2:399-403, 1987
43.
Cooper JW: Consulting to long term care patients, in Brown TR, Smith MC (eds): Institutional Pharmacy Practice, (ed 2). Baltimore, Williams and Wilkins, 1986, pp 649-662
